A Malignant Pheochromocytoma in a Child with von Hippel-Lindau Mutation

Authors

  • Gheorghe Popa
  • Cristina Lucia Blag
  • Mădălina Bota
  • Adriana Zolog

DOI:

https://doi.org/10.15386/cjmed-760

Keywords:

malignant pheocromocytoma, von Hippel-Lindau mutation, child

Abstract

Pheochromocytoma is a rare neuroendocrine tumor that arises from the chromaffin cells of the sympathetic nervous system. Over one third of pheochromocytomas are associated with germline mutations. We describe a 3 year-old girl with an inherited right adrenal malignant pheochromocytoma, with the mother diagnosed with von Hippel-Lindau syndrome. Genetic tests revealed the presence of the VHL c 244 C>G (p. Arg 82 Gly) heterozygote mutation in the mother, as well as in the child. After 6 months from the complete resection of the tumor, the patient is without any clinical symptoms, with normal blood pressure, normal ophthalmoscopy, no tumor markers and no evidence of tumor on cerebral or abdominal MRI. Lifelong complex follow-up is needed, as it is known that at a later age VHL mutation may cause retinal angiomas, cerebellar and spinal hemangioblastomas, relapsed pheocromocytoma, pancreatic and renal cysts, clear cell renal cell carcinoma and endolymphatic sac tumors.

 

Author Biographies

Gheorghe Popa, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Cristina Lucia Blag, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Mădălina Bota, University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Department of Pediatrics II

Children's Hospital Cluj Napoca, Department of Pediatrics II

Downloads

Published

2017-07-25

How to Cite

1.
Popa G, Blag CL, Bota M, Zolog A. A Malignant Pheochromocytoma in a Child with von Hippel-Lindau Mutation. Med Pharm Rep [Internet]. 2017 Jul. 25 [cited 2025 Oct. 5];90(3):356-8. Available from: https://medpharmareports.com/index.php/mpr/article/view/760

Issue

Section

Case Report